Variable | Endoscopies for patients with COVID-19 (N=19) | Endoscopies for patients without COVID-19 (N=61) | P value |
Age, years | 60 (51–73) | 64 (50–75) | 0.78 |
Male sex | 14 (73.7%) | 35 (57.4%) | 0.28 |
Admitted due to an upper gastrointestinal bleed | 4 (21.1%) | 39 (63.9%) | 0.001* |
Endoscopy within 24 hours of referral | 14 (73.7%) | 45 (73.8%) | >0.99 |
Consultant present at endoscopy | 14 (73.7%) | 42 (68.9%) | 0.78 |
Endoscopy performed out of hours | 4 (21.1%) | 13 (21.3%) | >0.99 |
Endoscopy performed on critical care | 8 (42.1%) | 10 (16.4%) | 0.03 |
Pre-endoscopy Glasgow Blatchford Score | 10.6 (3.7) | 9.8 (3.4) | 0.39 |
Bleed secondary to variceal haemorrhage | 1 (5.3%) | 12 (19.7%) | 0.17 |
Interventions performed during endoscopy | 5 (26.3%) | 22 (36.1%) | 0.58 |
Haemostasis achieved during endoscopy | 14 (73.7%) | 56 (91.8%) | 0.05 |
Postendoscopy Rockall Score | 5.1 (2.0) | 4.9 (2.0) | 0.82 |
Hospital length of stay, days | 17 (4–32) | 10 (4–19) | 0.16 |
30-day major rebleed incidence | 8 (42.1%) | 18 (29.5%) | 0.40 |
30-day survival | 11 (57.9%) | 50 (82.9%) | 0.06 |
Categorical data are described as n (%). Age and hospital length of stay are described as median (IQR). Normally distributed data (pre-endoscopy Glasgow Blatchford Score and postendoscopy Rockall Score) are described as mean (SD).
*Statistical significance following correction for false discovery.